Article
Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C.
Journal of medical virology - 1 Mar 1995
Garson J A, Brillanti S, Whitby K, Foli M, Deaville R, Masci C, Miglioli M, Barbara L
Abstract excerpt
Interferon alpha (IFN-alpha) therapy is currently the treatment of choice for chronic hepatitis C (HCV) infection, but it fails to achieve a sustained response in approximately 75% of those treated. The factors which determine whether or not an individual will respond to IFN-alpha are uncertain, although a number of potentially predictive factors have been proposed. In this study a wide range of clinical,...
Topics
- Adult
- Alanine Transaminase
- Aspartate Aminotransferases
- Genotype
- Hepacivirus
- Hepatitis C
- Hepatitis, Chronic
- Humans
- Interferon-alpha
- Prospective Studies
- RNA, Viral
